日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multiple Kinase Small Molecule Inhibitor Tinengotinib (TT-00420) Alone or With Chemotherapy Inhibit the Growth of SCLC

多激酶小分子抑制剂替尼替尼（TT-00420）单独使用或与化疗联合使用可抑制小细胞肺癌的生长

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.16450
Li, Hui; Tang, Chenchen; Zhao, Peiyan; Zhong, Rui; Lu, Yuanhua; Liu, Yan; Li, Rixin; Lan, Shaowei; Wu, Chunjiao; Qiang, Xiaoyan; Peng, Peng; Wu, Frank; Cheng, Ying; Liu, Ying
肺癌
肿瘤
肿瘤免疫
信号转导
细胞生物学
发表日期：2025
文献求助 收藏

Evaluation of disparities in hospitalisation outcomes for deaf and hard of hearing patients with COVID-19: a multistate analysis of statewide inpatient databases from Florida, Maryland, New York and Washington

对新冠肺炎聋人和听力障碍患者住院治疗结果差异的评估：一项基于佛罗里达州、马里兰州、纽约州和华盛顿州全州住院数据库的多州分析

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-089470
Sakai-Bizmark, Rie; Kumamaru, Hiraku; Lee, Jong Hyon; Estevez, Dennys; Wu, Frank; Marr, Emily H; Miller, Loren G
肺炎
新冠
微生物学
发表日期：2025
文献求助 收藏

Short Interpregnancy Intervals Among Women Experiencing Homelessness in Colorado

科罗拉多州无家可归女性的妊娠间隔较短

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.50242
Sakai-Bizmark, Rie; Jackson, Nicholas J; Wu, Frank; Marr, Emily H; Kumamaru, Hiraku; Estevez, Dennys; Gemmill, Alison; Moreno, Jessica C; Henwood, Benjamin F
发表日期：2024
文献求助 收藏

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

Tinengotinib (TT-00420)（一种多激酶抑制剂）作为单药治疗晚期实体瘤患者的首次人体I期研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad338
Piha-Paul, Sarina A; Xu, Binghe; Dumbrava, Ecaterina E; Fu, Siqing; Karp, Daniel D; Meric-Bernstam, Funda; Hong, David S; Rodon, Jordi A; Tsimberidou, Apostolia M; Raghav, Kanwal; Ajani, Jaffer A; Conley, Anthony P; Mott, Frank; Fan, Ying; Fan, Jean; Peng, Peng; Wang, Hui; Ni, Shumao; Sun, Caixia; Qiang, Xiaoyan; Levin, Wendy J; Ngo, Brenda; Ru, Qinhua Cindy; Wu, Frank; Javle, Milind M
信号转导
Human
发表日期：2024
文献求助 收藏

Kawasaki Disease Before and During the COVID-19 Pandemic: A Nationwide Population-based Study in the United States

新冠疫情前后川崎病：一项基于美国全国人口的研究

期刊:Pediatric Infectious Disease Journal
影响因子:2.2
doi:10.1097/INF.0000000000004095
Sakai-Bizmark, Rie; Estevez, Dennys; Wu, Frank; Marr, Emily H; BenDavid, Eyal; Mena, Laurie A; Chang, Ruey-Kang R
微生物学
新冠
发表日期：2024
文献求助 收藏

Pharmacokinetics, Mass Balance, and Biotransformation of [(14)C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects

健康受试者体内新型多靶点激酶抑制剂[(14)C]tinengotinib的药代动力学、质量平衡和生物转化

期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-024-00486-2
Ni, Shumao; Ma, Sheng; Yu, Yingying; Yu, Zhenwen; Zhu, Yujia; Sun, Xiaofen; Li, Lin; Sun, Caixia; Wang, Hui; Peng, Peng; Gu, Zheming; Zhang, Hua; Wu, Frank; Miao, Liyan; Fan, Jean
信号转导
发表日期：2024
文献求助 收藏

A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation

RUNX1 在调控巨核细胞引发的造血干细胞分化中发挥关键作用

期刊:Blood Advances
影响因子:7.4
doi:10.1182/bloodadvances.2022008591
Chen Wang, Zhaowei Tu, Xiongwei Cai, Weinan Wang, Ashely K Davis, Kalpana Nattamai, Aditi Paranjpe, Philip Dexheimer, Jianqiang Wu, Frank Lei Huang, Hartmut Geiger, Gang Huang, Yi Zheng
发育与干细胞
干细胞
发表日期：2023
文献求助 收藏

Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer

Tinengotinib (TT-00420) 是一种新型的谱选择性小分子激酶抑制剂，对三阴性乳腺癌具有很高的活性。

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-22-0012
Peng, Peng; Qiang, Xiaoyan; Li, Guoyu; Li, Lin; Ni, Shumao; Yu, Qi; Sourd, Laura; Marangoni, Elisabetta; Hu, Chao; Wang, Dong; Wu, Di; Wu, Frank
信号转导
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Pulse Oximetry Screening: Association of State Mandates with Emergency Hospitalizations

脉搏血氧饱和度筛查：州政府强制规定与急诊住院率之间的关联

期刊:Pediatric Cardiology
影响因子:1.4
doi:10.1007/s00246-022-03027-3
Sakai-Bizmark, Rie; Kumamaru, Hiraku; Marr, Emily H; Bedel, Lauren E M; Mena, Laurie A; Baghaee, Anita; Nguyen, Michael; Estevez, Dennys; Wu, Frank; Chang, Ruey-Kang R
发表日期：2023
文献求助 收藏

Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.

新型蛋白激酶抑制剂 TT-00420 通过抑制 JNK/JUN 介导的信号通路来抑制胆囊癌。

期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-022-00692-7
Miao Huijie, Geng Yajun, Li Yang, Tang Shijie, Feng Feiling, Li Weijian, Li Yongsheng, Liu Liguo, Zhang Rui, Qiu Shimei, Wu Ying, Wang Zeyu, Wang Ziyi, Shao Ziyu, Liu Ke, Zou Lu, Yang Mao, Zhao Yuhao, Chen Chen, Li Zhizhen, Zhang Dadong, Peng Peng, Qiang Xiaoyan, Wu Frank, He Yongning, Chen Luonan, Xiang Dongxi, Jiang Xiaoqing, Li Maolan, Liu Yun, Liu Yingbin
肿瘤
肿瘤免疫
信号转导
胆囊癌
JNK
JUN
发表日期：2022
文献求助 收藏